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Abstract A mutated excisionase (Xis) protein of coliphage
HK022 whose single Cys residue was replaced by Ser does
not bind to its two tandem binding sites (X1, X2) on the
P arm of attR. Despite its DNA-binding inability the protein
showed 30% excision activity of the wild type Xis both in vitro
and in vivo. This partial activity is attributed to the interaction
of Xis with integrase that is retained in the mutant protein. This
protein^protein interaction occurs in the absence of DNA bind-
ing.
, 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The excisionase (Xis) proteins encoded by bacteriophages V
and HK022 di¡er in one amino acid and are functionally
identical [1]. They belong to the family of recombination di-
rectionality factors that direct site-speci¢c recombination re-
actions towards excision by inhibiting integration [2]. The site-
speci¢c integration and excision reactions of each phage are
catalyzed by the phage-encoded integrase (Int) protein. Inte-
gration results from a crossover between two 21 bp long core
sites on the Escherichia coli DNA (attB, or BOBP) and a
similar core (attP or COCP) on the phage DNA (Fig. 1).
attP is much larger than attB because its core is £anked by
two longer arms (P and PP) that carry binding sites for Int and
for accessory proteins that are essential for the site-speci¢c
recombination reactions. To catalyze the integrative (attB
UattP) reaction Int requires the host-encoded accessory pro-
tein, integration host factor (IHF). As a result, the integrated
prophage is £anked by the recombinant attL and attR sites,
which are the sites for the reverse excision reaction. In addi-
tion to Int and IHF, the excision reaction (attLUattR) re-
quires Xis. Factor for inversion stimulation (FIS) is a third
host-encoded accessory protein that can assist excision when
the concentration of Xis is low. All three accessory proteins
(IHF, Xis and FIS) are DNA bending proteins that bind to
the P and PP arms and thereby facilitate access of arm-bound
Int monomers to the core (reviewed by [3,4]).
Xis binds cooperatively to two tandem binding sites (X1,
X2) on the P arm, each of 13 bp (Fig. 1). X2 overlaps with F,
a single binding site for FIS. Xis plays a dual role in directing
the formation of the excisive DNA^protein complex (known
as the intasome). In addition to its DNA bending properties
Xis interacts with Int monomers to divert their binding from
the P1 arm binding site to the P2 site [5,6]. Xis is a small
protein of 72 amino acids composed of two domains, an ami-
no-terminal DNA binding domain (amino acids 1^53) and a
carboxy-terminal domain (amino acids 54^72) that interacts
with Int [7^9]. In a recent work we have shown that in an attR
site that carries a mutations in both Xis binding sites (X1 and
X2) the binding ability of Xis is abolished. Nevertheless this
double mutant allows 25% of the wild type excision activity in
vivo as well as in vitro [10]. In this work, we con¢rm this
observation and demonstrate that DNA binding of Xis is
not required for its interaction with Int.
2. Materials and methods
2.1. Bacteria, phage and plasmids
These are listed in Table 1.
2.2. Construction and cloning of the plasmid that expresses the
C28S Xis mutation
The xis mutation with the Cys to Ser substitution (xisC28S)
was constructed by a polymerase chain reaction (PCR) that used
plasmid pPG15 as template. One oligomer carried the T7 terminator
sequence of the vector pET14b (Novagen) and the other oligomer
(oEY141, 5P-GCCTTGAAACAGTTCGTCGATGGGTGCGCGAA-
TcCAGG) carried the mutation (in lower case) and a native XmnI
restriction site (underlined). The PCR product and plasmid pPG15
were each restricted with the enzymes XmnI and XhoI (the latter
site belongs to the linker) and the PCR product was cloned into
pPG15 replacing the corresponding wild type sequence. DNA se-
quencing con¢rmed the presence of the xisC28S mutation and the
plasmid that carries it was designated pPG165.
2.3. Isolation of a phage that carries the xisY2C mutation
pLD177 is an excision reporter plasmid that is speci¢c to phage V.
Wild type V phage forms blue plaques in the presence of Xgal on a
vlac host (TAP114) transformed with pLD177 [11]. Phage strain
Y1096 carries int and xis of HK022 and does not form blue plaques
under these conditions. However, it does form blue plaques on the
same host that is lysogenic with the V prophage B225 (strain EY1604),
because the prophage that is mutated in xis supplies Int-V and phage
Y1096 supplies Xis. Y1096 was mutagenized by growing the phage on
a mutD mutator host (strain LE30) and plated on strain EY1604 in
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the presence of Xgal. Rare white plaques are expected to have resulted
from a mutation in xis of HK022. Four such plaques were isolated;
their region of xis was ampli¢ed by PCR and the DNA sequence in
two of them showed that the Tyr2 codon (UAC) of xis has been
changed to a codon of Cys (UGC). One of the mutant strains was
designated EY261 and the mutation was designated xisY2C.
2.4. Protein puri¢cation
Wild type and the C28S mutant Xis were puri¢ed as described [12]
from an isopropyl L-D-thiogalactopyranoside-induced culture of strain
BL21(DE3) (pLys) [13] transformed with plasmids pPG15 or pPG165.
The N-terminal Int164 peptide was cloned into the expression vector
pETI1 [14] (plasmid pVB262), overexpressed and puri¢ed using a
phosphocellulose column according to Nash [15]. Int56357 was cloned
and expressed in vector pET14m [10] (plasmid pMK60) and the His-
tagged peptide was puri¢ed on a nickel column resin according to the
Novagen pET system manual. This fragment showed a high topoiso-
merase activity [16] (not shown). Puri¢ed IHF was a gift of Carol
Robertson and Howard Nash.
2.5. Gel shift assay
Reactions (10 Wl) were as previously described [12]. In Fig. 2 the
concentrations of Xis were 0.2, 0.4, 0.8 and 1.6 WM. In Fig. 6 protein
concentrations were 0.2 WM Xis and 0.3, 0.6 and 1.2 WM of Int.
2.6. In vitro excision assay
This assay was done as previously described [10].
2.7. In vivo excision assay
Lysogenic cells were grown logarithmically in a rich medium to a
density of A600 = 1.2. The cells were centrifuged and the titer of free
phage released to the supernatant was determined by a viable count.
2.8. Fluorescence resonance energy transfer (FRET) analysis
Xis protein was labeled with the £uorescence probe £uorescein-5-
isothiocyanate (FITC). Int and its derivative peptides Int164 and
Int56357 were each labeled with tetramethylrhodamine-5- (and 6-)
isothiocyanate (TRITC) [17]. Prior to the reactions all the proteins
were dialyzed against 600 mM KCl, 50 mM phosphate bu¡er, pH 8,
and concentrated up to 2 mg/ml. Fifty Wl of a solution of either 1 mg/
ml FITC or 2 mg/ml TRITC were added to 950 Wl of the relevant
conjugated protein. The mixture was incubated in the dark at 4‡C
with constant shaking. After 3 h the mixture was dialyzed against
600 mM KCl, 50 mM K2HPO4, 1 mM EDTA and 10% glycerol at
pH 7 until no free £uorescence probe could be observed. The amounts
of FITC or TRITC bound to proteins were estimated by absorbance
at 499 and 544 nm (molar extinction coe⁄cients O=68 000 for FITC
O=84 000 for TRITC). The degree of labeling was 15% for Xis-FITC,
30% for Int-TRITC, 25% for Int164-TRITC and 33% for Int56357-
TRITC conjugates.
Energy transfer measurements were carried out using an LS50B
Perkin-Elmer luminescence spectrometer. Two WM Xis-FITC conju-
gate was mixed with equimolar amounts of the di¡erent TRITC con-
jugates and emission data were collected every 2 min. The excitation
wavelength was set at 490 nm and the emission intensity was moni-
tored between 500 nm and 630 nm.
3. Results
3.1. Xis is partially active in the absence of DNA binding
Xis carries a single cysteine residue at position 28 that re-
sides in its DNA binding domain. We have constructed an
Xis-overexpressing plasmid (pPG165) whose single Cys resi-
Table 1
Bacteria, phage and plasmids
Relevant genotype Source
Bacteria
EY1659 MG1655 (HK022 xisY2C) This study
EY1604 pLD177 in TAP114(B225) This study
EY1662 MG1655 (OR228) This study
EY1663 RJ1800 (Y1096 xisY2C) This study
EY1666 RJ1800 (HK022) This study
RJ1800 MG1655 ¢s : :Km767 [22]
LE30 mutD5 [11]
MG1655 Wild type [23]
TAP114 v(lacZ)M15 [11]
Phage
B225 V intc xis [24]
Y1096 attP-int-xis-HK022 imm-V cI857 [1]
OR228 HK022 wild type [1]
EY261 Y1096 xisY2C This study
Plasmids
pPG15 His-tag xis-HK022 cloned in
pET14m
[10]
pLD177 A reporter plasmid for V excision [11]
pMK60 Int56357 cloned in pET14m This work
pPG123 attR-t1t2-attL cloned in pBluescript [10]
pPG165 xisC28S-HK022 mutant cloned in
pET14m
This work
pVB262 Int164 cloned in pETI1 This work
Fig. 1. A: Schematic presentation of the att sites involved in the site-speci¢c recombination reaction of bacteriophages V and HK022. COCP,
BOBP, COBP, and BOCP are the core sites of attP, attB, attR, and attL, respectively. P indicates arm binding sites for Int, X for Xis, H for
IHF and F for Fis. The sequences of the two Xis binding sites X1 and X2 in attR of V and of HK022 are aligned.
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due was replaced by a Ser residue (C28S). Wild type Xis and
the mutant Xis were overexpressed, puri¢ed and used in a gel
shift assay to observe binding to a labeled HK022 attR frag-
ment of 450 bp (Fig. 2). The wild type protein retarded the
DNA fragment by forming two slower moving bands (Fig.
2A). In the ¢rst band (X1) Xis is bound to X1, and in the
second band (X1X2) Xis is bound to both sites. Due to a
strong binding cooperativity X1X2 is the major band at all
concentrations of Xis [6,10]. The mutant Xis protein that
challenged the attR sites at the same concentrations was com-
pletely unable to bind (Fig. 2B).
The activity of the C28S mutant protein was tested in vitro
and in vivo. In the in vitro reaction the substrate (plasmid
pPG123) carried the attL and attR sites in tandem and a
single XhoI site that is located on the vector. Excisional re-
combination between attL and attR on the same plasmid (re-
action in cis) is expected to yield two smaller plasmids. Line-
arization of the reaction products with XhoI, followed by
radioactive end labeling, is expected to yield a linear product
of 3 kb that is shorter than the original substrate of 4 kb. Fig.
3, lane a shows the substrate alone and in lane b Xis was
omitted from the reaction. Lane c shows the full reaction
(Xis, Int and IHF) using the wild type Xis. Lane d shows
the full reaction using a similar concentration of the mutant
Xis. The 3 kb product is shown with the black arrow. The
weak and longer product (open arrow) that is observed
mainly in lane c is the product of a recombination event in
trans (between two substrates) that is expected to yield two
linear products of 5 and 3 kb. Quantitation has shown that
the C28S mutant exhibited 30% of the wild type activity.
To test the activity of the C28S mutant in vivo we selected
an HK022 phage that was mutated in xis (see Section 2). A
sequence analysis has shown that in this mutant a Tyr residue
at position 2 of Xis was replaced with a Cys residue (xisY2C).
Viable phage released in a liquid culture of a lysogen that
carries the xisY2C mutation (strain EY1659) was compared
to the phage excised from a lysogen that carried the wild type
HK022 prophage (strain EY1662). Fig. 4, columns A and B
show that excision of free phage (V1U108/ml) was identical
in both lysogens. However, when we compared two similar
lysogens whose host’s ¢s gene was inactivated (¢s : :Km) the
xisY2C lysogen (strain EY1663, column D) released over one
order of magnitude less phage (9.5U105 phage/ml) than did
the comparable lysogen with the wild type HK022 prophage
(strain EY1666, column C, 1.6U107 phage/ml). Thus, the
Fig. 2. Gel shifts of an attR site by wild type (A) and mutant C28S
Xis (B). Triangles represent the increasing concentrations of Xis (0.2
WM, 0.4 WM, 0.8 WM and 1.6 WM); S indicates the labeled sub-
strates (0.02 WM); X1 and X1X2 are Xis^DNA complexes.
Fig. 3. In vitro excision assay catalyzed by wild type and by C28S
mutant Xis. The concentration of Xis was 0.2 WM. a: Substrate
only. b: The reaction mixture in the absence of Xis. c: Full reaction
with the wild type Xis. d: Full reaction with the C28S mutant Xis.
The black arrow shows the product of the reaction. The open arrow
shows the weak 5 kb product of the reaction in trans.
Fig. 4. Titers of free phage in lysogenic strains. A: Wild type lyso-
gen with a wild type HK022 prophage (strain EY1662). B: Wild
type lysogen with an HK022xisC2Y prophage (strain EY1659). C:
¢s : :Km lysogen with a wild type HK022 prophage (strain EY1666).
D: ¢s : :Km lysogen with an HK022xis1 prophage (strain EY1663).
Fig. 5. Relative phage excision by strain EY1663 [¢s : :Km(HK022
xisY2C)] transformed with the vector pET14m (column A), with
pPG15 (column B) and with pPG165 (column C). The numbers
above each column indicate the actual average phage titer/ml of
three experiments.
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xisY2C mutation is expressed only in the absence of FIS. It is
also noteworthy that in the ¢s : :Km host less wild type HK022
phage was released as compared to the wild type host (com-
pare columns C and A). In order to test to what extent the
C28S Xis protein can help the xisY2C mutant prophage to
excise we transformed the ¢s : :Km(xisY2C) lysogen (strain
EY1663) with the plasmid that expresses the C28S Xis
(pPG165) or with the plasmid that expresses the wild type
Xis (pPG15). Phage release of these two lysogenic transform-
ants along with a control strain transformed with the vector
plasmid is shown in Fig. 5. The results of three experiments
show that the C28S mutant protein (Fig. 5, column C) stimu-
Fig. 6. Gel shifts of attR sites (lane 1) challenged with Xis (lane 2),
with Xis and increasing amounts (0.3, 0.6 and 1.2 WM) of Int (col-
umns 3^5) and with the same increasing amounts of Int alone (lanes
6^8). A: Wild type Xis and wild type attR. B: Wild type Xis and
attR mutated in the X1 and X2 sites. C: C28S mutant Xis and wild
type attR.
Fig. 7. Xis^Int interactions assayed by FRET analyses. A: Xis^Int.
B: Xis^Int164. C: Xis^Int56357.
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lated an average of 30% phage release as compared to the wild
type (column B). Thus, the in vivo assay con¢rmed the in
vitro results.
3.2. Xis^Int interaction
The C-terminal domain of Xis is responsible for its inter-
action with Int to divert Int binding to the P2 arm binding
site, thereby favoring the excision reaction [5^8]. We tested if
the C28S-mutated Xis, which cannot bind to its site on DNA
but shows partial excision activity, can still interact with Int.
Fig. 6 shows gel retardation assays of labeled attR sites (lane
1) challenged with Xis alone (lane 2), Xis with increasing
amounts of Int (lanes 3^5) and increasing amounts of Int
alone (lanes 6^8). In Fig. 6A attR and Xis were both wild
type. As shown above (Fig. 2) Xis alone binds cooperatively
to the X1X2 sites (Fig. 6A, lane 2) and in the presence of
increasing amounts of Int it forms a predominant slower mov-
ing complex (P2, lanes 3^5) that is, presumably, due to a
DNA-bound Xis^Int complex that is located on the P2 site.
This site is hardly occupied in the presence of Int alone (lanes
6^8). In Fig. 6B the challenged attR fragment was mutated in
both X1 and X2 sites that prevent binding of Xis (lane 2 and
[10]). Nevertheless, in the presence of increasing amounts of
Int the wild type Xis again recruits Int to the presumed P2 site
that is hardly occupied by Int alone. In Fig. 6C the attR was
wild type and Xis carried the C28S mutation. Here also the
mutant Xis, which is not able to bind to attRþ (lane 2 and
Fig. 2), recruits Int to the P2 site, though less extensively than
does the wild type Xis. These results demonstrate that Xis can
direct Int to bind to the P2 site independently of its ability to
bind to DNA.
3.3. FRET analyses
To test whether Xis and Int can interact in the absence of
DNA we used a FRET assay. Since e⁄cient FRET requires
close proximity (6 100 AU ) between a donor and acceptor
group, a signi¢cant FRET process is consistent with direct
physical interaction [18]. Puri¢ed Xis was conjugated with
FITC and puri¢ed Int was conjugated with TRITC (excita-
tion/emission wavelength maxima of 490/518 and 550/580, re-
spectively) and the spectral overlap results in a R0 value of
about 55 AU [17]. The two labeled proteins were mixed at an
equimolar ratio to a ¢nal concentration of 2 WM and were
subjected to an excitation of Xis-FITC at 490 nm. The emis-
sion of Xis-FITC at 518 nm and that of Int-TRITC at 580 nm
(Fig. 7A) shows that the mixing has resulted in a decline in
the emission of the labeled Xis at 518 nm coupled with a
corresponding increase in the emission of Int at 580 nm as
a result of energy transfer from the conjugated Xis to the
conjugated Int. These results are consistent with a direct phys-
ical interaction between the two proteins. Recent evidence has
indicated that the amino-terminal arm binding domain of Int
(residues 1^64 [5,19]) is responsible for the Xis^Int interaction
[20]. We cloned and puri¢ed separately residues 1^64 of Int
and a C-terminal fragment of Int that included residues 56^
357 and subjected them to an identical FRET analysis with
Xis. FRET is observed between Xis and the Int164 fragment
(Fig. 6B), although the latter carries only one Lys residue for
binding to the £uorophore, whereas FRET is not observed
between Xis and Int55357 (Fig. 6C), although this fragment
contains 24 Lys residues. These results con¢rm that Xis in-
deed interacts with the N-terminal part of Int.
4. Discussion
In this work we have demonstrated that the C28S-mutated
Xis protein of HK022 is unable to bind to its X1X2 sites on
the P arm of att (Fig. 2); nevertheless, it shows 30% activity of
the wild type Xis, both in vitro (Fig. 3) and in vivo (Fig. 5).
This con¢rms our previous observation that wild type Xis,
when unable to bind to mutated X1X2 sites, also shows a
similar activity [10] and indicates that Xis can be partially
active in the absence of DNA binding. This partial activity
that is independent of DNA binding can be attributed to the
Xis^Int interaction that is retained in the C28S mutant pro-
tein (Fig. 6). In the gel shift experiments reported above as
well as in the V system [5] the Xis^Int interaction was dem-
onstrated while Int was bound to DNA. This does not exclude
the possibility that some kind of DNA binding is a prerequi-
site for the Xis^Int interaction. However, the FRET experi-
ments (Fig. 7) indicate that interaction exists in the absence of
DNA. Mutations and deletions of Xis in its C-terminal do-
main also show partial excision activity [21,7]. Therefore, each
of the two functions of Xis (DNA binding and Xis^Int inter-
action) contributes independently to the full excision activity.
Sam et al. [21] have constructed a similar C28S mutation in
Xis of phage V that, in contrast to the same mutation in
HK022, binds normally to attR-V. This discrepancy is di⁄cult
to explain because the Xis proteins of the two phages di¡er in
only one amino acid at position 59 that does not belong to the
DNA binding domain and the two proteins are functionally
interchangeable [1]. The sequences of the X1 X2 binding sites
of HK022 have only been deduced from their homology with
the V sites, and they show some di¡erence between them (Fig.
1). The X1 sites di¡er in one bp and the X2 sites di¡er in three
bp. Perhaps this is the reason for the di¡erences in the binding
ability of the two C28S mutants.
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